AGEN
AGEN
NASDAQ · Biotechnology

Agenus Inc

$3.39
-0.05 (-1.45%)
As of Mar 29, 10:42 PM ET ·
Financial Highlights (FY 2026)
Revenue
169.99M
Net Income
-373,304,679
Gross Margin
99.5%
Profit Margin
-219.6%
Rev Growth
-29.5%
D/E Ratio
0.41
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 99.5% 99.5% 42.9% 42.9%
Operating Margin -116.4% -104.8% -12.1% -11.8%
Profit Margin -219.6% -208.6% -13.6% -13.8%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 169.99M 241.22M 22.23M 24.20M
Gross Profit 169.19M 240.09M 9.53M 10.37M
Operating Income -197,934,016 -252,789,292 -2,685,737 -2,845,163
Net Income -373,304,679 -476,762,042 -3,026,461 -3,348,387
Gross Margin 99.5% 99.5% 42.9% 42.9%
Operating Margin -116.4% -104.8% -12.1% -11.8%
Profit Margin -219.6% -208.6% -13.6% -13.8%
Rev Growth -29.5% -29.5% +14.5% +15.7%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 19.01M 19.01M 13.67M 12.56M
Total Equity 46.09M 46.09M 33.53M 40.20M
D/E Ratio 0.41 0.41 0.41 0.31
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -172,933,843 -233,130,624 -4,014,681 -4,691,998
Free Cash Flow -2,971,274 -2,303,520